BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 37118735)

  • 41. Cervical cancer risk perceptions, sexual risk behaviors and sexually transmitted infections among Bivalent Human Papillomavirus vaccinated and non-vaccinated young women in Uganda - 5 year follow up study.
    Kumakech E; Andersson S; Wabinga H; Musubika C; Kirimunda S; Berggren V
    BMC Womens Health; 2017 Jun; 17(1):40. PubMed ID: 28576143
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rationale and design of a multicenter prospective cohort study for the eVALuation and monitoring of HPV infections and relATEd cervical diseases in high-risk women (VALHIDATE study).
    Orlando G; Tanzi E; Chatenoud L; Gramegna M; Rizzardini G;
    BMC Cancer; 2012 May; 12():204. PubMed ID: 22646512
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevalence of high-risk human papillomavirus infections and associated factors among women living with HIV in Shashemene town public health facilities, Southern Ethiopia.
    Megersa T; Dango S; Kumsa K; Lemma K; Lencha B
    BMC Womens Health; 2023 Mar; 23(1):125. PubMed ID: 36959649
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Human papillomavirus genotypes distribution by cervical cytologic status among women attending the General Hospital of Loandjili, Pointe-Noire, Southwest Congo (Brazzaville).
    Boumba LM; Qmichou Z; Mouallif M; Attaleb M; El Mzibri M; Hilali L; Donatien M; Ennaji MM
    J Med Virol; 2015 Oct; 87(10):1769-76. PubMed ID: 25963674
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence of high-risk human papillomavirus infection and cervical lesions among female migrant head porters (kayayei) in Accra, Ghana: a pilot cross-sectional study.
    Tekpor E; Effah K; Sifa J; Amuah JE; Essel NOM; Kemawor S; Wormenor CM; Sesenu E; Danyo S; Akakpo PK
    BMC Public Health; 2024 Mar; 24(1):659. PubMed ID: 38429784
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Comparison of high-risk human papillomavirus infection rate and genotype distribution between Han and Mongolian women].
    Zhao S; Zhao XL; Hu SY; Wang Y; Remila R; Xu XQ; Duan XZ; Chen F; Zhang X; Zhao FH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Nov; 40(11):1439-1444. PubMed ID: 31838818
    [No Abstract]   [Full Text] [Related]  

  • 47. Pre-vaccination prevalence of infections with 25 non-high-risk human papillomavirus types among 1,000 Slovenian women in cervical cancer screening.
    Učakar V; Poljak M; Oštrbenk A; Klavs I
    J Med Virol; 2014 Oct; 86(10):1772-9. PubMed ID: 24978445
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevalence and concordance of high-risk papillomavirus infection in male sexual partners of women diagnosed with high grade cervical lesions.
    López Diez E; Pérez S; Iñarrea A; de la Orden A; Castro M; Almuster S; Tortolero L; Rodríguez M; Montero R; Ojea A
    Enferm Infecc Microbiol Clin; 2017 May; 35(5):273-277. PubMed ID: 27004428
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High prevalence of and factors associated with human papillomavirus infection among women attending a tertiary hospital in Gauteng Province, South Africa.
    Tiiti TA; Selabe SG; Bogers J; Lebelo RL
    BMC Cancer; 2022 Aug; 22(1):854. PubMed ID: 35931978
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Detection of 14 High-risk Human Papillomavirus (HPV) Genotypes Within the Italian Cervical Cancer Screening.
    Cenci M; Rossi F; Pisani T
    In Vivo; 2023; 37(5):2161-2165. PubMed ID: 37652482
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevalence of cervical human papillomavirus infection in healthy women is related to sexual behaviours and educational level: a cross-sectional study.
    Tay SK; Oon LL
    Int J STD AIDS; 2014 Dec; 25(14):1013-21. PubMed ID: 24648316
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human papillomavirus infection and associated factors for cervical intraepithelial neoplasia in women living with HIV in China: a cross-sectional study.
    Wang Q; Ma X; Zhang X; Ong JJ; Jing J; Zhang L; Wang LH
    Sex Transm Infect; 2019 Mar; 95(2):140-144. PubMed ID: 30337414
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effectiveness of Clinic-Based Patient-Led Human Papillomavirus DNA Self-Sampling among HIV-Infected Women in Uganda.
    Nyabigambo A; Mayega RW; Ginindza TG
    Int J Environ Res Public Health; 2023 Aug; 20(16):. PubMed ID: 37623195
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human papillomavirus prevalence and genotype distribution among HIV-infected women in Korea.
    Park EK; Cho H; Lee SH; Lee SG; Lee SY; Kim KH; Lee CH; Chung JS; Kwak IS
    J Korean Med Sci; 2014 Jan; 29(1):32-7. PubMed ID: 24431902
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High-Risk human papillomavirus genotype distribution in the Northern region of Portugal: Data from regional cervical cancer screening program.
    Sousa H; Tavares A; Campos C; Marinho-Dias J; Brito M; Medeiros R; Baldaque I; Lobo C; Leça L; Monteiro P; Tavares F; Henrique R
    Papillomavirus Res; 2019 Dec; 8():100179. PubMed ID: 31377173
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HPV prevalence in women attending cervical screening in rural Malawi using the cartridge-based Xpert
    Cubie HA; Morton D; Kawonga E; Mautanga M; Mwenitete I; Teakle N; Ngwira B; Walker H; Walker G; Kafwafwa S; Kabota B; Ter Haar R; Campbell C
    J Clin Virol; 2017 Feb; 87():1-4. PubMed ID: 27984765
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Prevalence of high-risk HPV and its distribution in cervical precancerous lesions among 35-64 years old women who received cervical cancer screening in Beijing].
    Shen J; Gao LL; Zhang Y; Han LL; Wang JD
    Zhonghua Yu Fang Yi Xue Za Zhi; 2018 May; 52(5):493-497. PubMed ID: 29747341
    [No Abstract]   [Full Text] [Related]  

  • 58. Prevalence and risk factors for carcinogenic human papillomavirus infections in rural Rakai, Uganda.
    Safaeian M; Kiddugavu M; Gravitt PE; Gange SJ; Ssekasanvu J; Murokora D; Sklar M; Serwadda D; Wawer MJ; Shah KV; Gray R
    Sex Transm Infect; 2008 Aug; 84(4):306-11. PubMed ID: 18385223
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Risk of seropositivity to multiple oncogenic human papillomavirus types among human immunodeficiency virus-positive and -negative Ugandan women.
    Namujju PB; Waterboer T; Banura C; Muwonge R; Mbidde EK; Byaruhanga R; Muwanga M; Surcel HM; Pawlita M; Lehtinen M
    J Gen Virol; 2011 Dec; 92(Pt 12):2776-2783. PubMed ID: 21832008
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A population based study on human papillomavirus infection and associated risk factors among women of the remote South Andaman Island, India.
    Parvez R; Vijayachari P; Thiruvengadam K; Roy A; Saha MK; Ramasamy J; Vins A; Biswas L; Vaz A; Kaur H; Nagarajan M
    BMC Womens Health; 2024 Feb; 24(1):139. PubMed ID: 38395851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.